Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (...
Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02)
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aim
Neoadjuvant chemoradiotherapy may improve survival in patients with advanced cholangiocarcinoma. This Phase I study aimed to determine the recommended dose of neoadjuvant chemoradiotherapy and decide whether to move to a Phase II study.
Methods
Patients diagnosed with resectable stage II–IVa cholangiocarcinoma were administered cisplat...
Alternative Titles
Full title
Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3a5bf4ceae1448998b78f8069acd2cbe
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a5bf4ceae1448998b78f8069acd2cbe
Other Identifiers
ISSN
2475-0328
E-ISSN
2475-0328
DOI
10.1002/ags3.12682
